Earlier this month I wrote a piece on Field Trip (FTRP.C) scaling their ketamine clinics after a huge $95M raise. I liked their business model, and Novamind’s (NM.C) is…
Psychedelics
There are two options when it comes to ingesting psychedelics, natural or synthetic. People have been tripping balls eating raw natural mushrooms for thousands of years, so why…
Aion Therapeutics (AION.C), formerly Osoyoos Cannabis, has filed four new patent applications related to preparations of medicinal and psychedlics mushrooms. This brings the Company’s total patent applications up to 9…
Canada: not a big push for rec Canada is a country typically at the forefront of forward-thinking movements in health and science. With the recent legalization of cannabis…
Cybin (CYBN.NE) is popping up on our breakout screeners, as the stock approaches the $1.50 resistance zone and is primed for a run. The technical pattern here is called…
Cybin’s (CYBN.NE) subsidiary Adelia Therapeutics completed earnout milestones originally set in a contribution agreement for the period of January 1, 2021, following Cybin’s acquisition of Adelia. There are a…
Pure Extracts Technologies (PULL.C) inked a letter of intent with ShroomBoom Labs/Floja Bioscience to supply psychedelic mushroom biomass today, according to a press release. The terms of the LOI…
Core One Labs (COOL.C) has announced they are collaborating with Ketamine Infusions Centers of Texas (KICT) to explore the development of a program for N-dimethyltryptamine (DMT) assisted psychotherapy to…
On March 22, 2021, Koios’ (KBEV.C) entire line of canned beverages will begin selling at all Metropolitan Market locations. “We have long maintained that local grocery chains are exceptionally…
+135k shares in a downturn, my man The psychedelics sector is down bad this week. Just look at the psychedelics ETF PSYK.NE. It’s not an alarm or…